Comparison of Acute and Chronic Surgical Complications Following Robot-Assisted, Laparoscopic, and Traditional Open Radical Prostatectomy Among Men in Taiwan

Wu, Szu-Yuan; Chang, Chia‐Lun; Chen, Chang-I; Huang, Chung Chien

doi:10.1001/jamanetworkopen.2021.20156

Cited by 37 publications

(35 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Symptoms of BPH, impotence, UI, urethral stricture, and hernia were recorded in medical records and treatments were accordance with the corresponding medical treatments. The records of BPH, impotence, UI, urethral stricture, and hernia were similar with the previous study ( 13 ). Patients with impotence, UI, urethral stricture, and hernia before the index date were excluded from this study.…”

Section: Methodssupporting

confidence: 88%

“…Our independent variables were therapy modalities (RP or IMRT+HT), age, diagnosis year, income, hospital area, hospital level (academic or nonacademic), clinical T stage, grade (maximum Gleason grade), pretreatment PSA (ng/mL), and D’Amico risk classification. The endpoints were acute (in the third month), subchronic complications (at 1 and 2 years), and late complications (at 3, 4, and 5 years) after receiving treatments (i.e., symptoms of benign prostatic hyperplasia [BPH], impotence, urinary incontinence [UI], urethral stricture, and hernia) ( 13 , 28 ). Symptoms of BPH, impotence, UI, urethral stricture, and hernia were recorded in medical records and treatments were accordance with the corresponding medical treatments.…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Acute, Subchronic, and Chronic Complications of Radical Prostatectomy Versus Radiotherapy With Hormone Therapy in Older Adults With High-Risk Prostate Adenocarcinoma

Huy

Liao

et al. 2022

Front. Oncol.

Self Cite

View full text Add to dashboard Cite

PurposeTo compare acute, subchronic, and chronic complications between older patients with high-risk localized prostate cancer (HR-LPC) receiving radical prostatectomy (RP) and high-dose intensity-modulated radiotherapy (IMRT) combined with long-term hormone therapy (HT).Patients and MethodsWe recruited older patients (≥80 years) with HR-LPC from the Taiwan Cancer Registry database. After propensity score matching, logistic regression analysis was used to compare the acute, subchronic, and chronic complication rates between patients who underwent RP (the RP group) and high-dose IMRT combined with long-term HT (the IMRT+HT group).ResultsBenign prostatic hyperplasia (BPH) symptoms and urinary incontinence (UI) were the most common complications over 5 years (BPH symptoms: RP, 17.69%; IMRT+HT, 29.58%; UI: RP, 10.47%; IMRT+HT, 5.50%). Compared with the RP group, the IMRT+HT group had higher odds of BPH symptoms and lower odds of UI and hernia after the 5-year follow-up period. The impotence rates were significantly higher in the IMRT+HT group than in the RP group at 3 months and 1 year after treatment and became nonsignificant after 2 years. At 5 years after treatment, the IMRT+HT group had lower risks of UI (adjusted odds ratio [aOR], 0.50; 95% confidence interval [CI], 0.28–0.88) and hernia (aOR, 0.21; 95% CI, 0.11–0.82) and a higher risk of BPH symptoms (aOR, 4.15; 95% CI, 2.82–7.37) than the RP group.ConclusionIMRT+HT was associated with lower UI and hernia risks than RP. By contrast, RP was associated with fewer complications of BPH over the follow-up period and less impotence during the first year after treatment. Our findings provide important and valuable references for shared decision-making for optimal therapy selection among older men with HR-LPC.

show abstract

Section: Methodssupporting

confidence: 88%

Section: Methodsmentioning

confidence: 99%

Acute, Subchronic, and Chronic Complications of Radical Prostatectomy Versus Radiotherapy With Hormone Therapy in Older Adults With High-Risk Prostate Adenocarcinoma

Huy

Liao

et al. 2022

Front. Oncol.

Self Cite

View full text Add to dashboard Cite

show abstract

“…Research based on the NHI database provides valuable data regarding cancer diagnosis, epidemiology, outcome, and treatment [56]. The TCRD in Taiwan is a compulsory system that requires all hospitals treating patients with cancer to provide valid clinical, laboratory, imaging, pathology, and personal data to the Ministry of Health and Welfare [57]. The data were validated and generally consistent in both the databases [58].…”

Section: Discussionmentioning

confidence: 95%

A Novel Predictive Scoring System for 90-Day Mortality among Patients with Hepatocellular Cell Carcinoma Receiving Major Hepatectomy

Soong

Chen

Chou

et al. 2022

Cancers

Self Cite

View full text Add to dashboard Cite

Purpose: Hepatocellular carcinoma (HCC) is a major malignancy and the common cause of cancer-related deaths. Surgical intervention provides superior long-term survival outcomes; however, perioperative mortality is a major concern for clinicians while making treatment decisions, especially for major hepatectomy. Scoring systems for predicting 90-day mortality in patients with HCC undergoing major hepatectomy are not available. Methods: This study used the Taiwan Cancer Registry Database that is linked to the National Health Insurance Research Database to analyze data of 60,250 patients with HCC who underwent major hepatectomy and determine risk factors to establish a novel predictive scoring system. By using the stepwise selection of the multivariate Cox proportional hazards model, we divided the patients with HCC undergoing major hepatectomy into four risk groups. Results: The Chang Gung-PohAi predictive scoring system exhibited significant differences in the 90-day mortality rate among the four risk groups (very low risk: 2.42%, low risk: 4.09%, intermittent risk: 17.1%, and high risk: 43.6%). Conclusion: The Chang Gung-PohAi predictive scoring system is a promising tool for predicting 90-day perioperative mortality in patients with HCC undergoing major hepatectomy.

show abstract

“…The study protocols were reviewed and approved by the Institutional Review Board of Tzu-Chi Medical Foundation (IRB109-015-B). Data from the cancer registry database of the Collaboration Center of Health Information Application, which contains detailed cancer-related information regarding pathological types, cancer stages, and treatments, were also used [ 17 , 18 , 19 , 20 ].…”

Section: Methodsmentioning

confidence: 99%

Survival Impact of Long-Term Tramadol Use on Breast Cancer for Patients with Chronic Pain: A Propensity Score-Matched Population-Based Cohort Study

Sun

Chang

et al. 2022

JPM

Self Cite

View full text Add to dashboard Cite

Purpose: The impact of tramadol analgesic use before breast cancer diagnosis on survival in patients with chronic pain is unclear. Therefore, we designed a propensity score-matched population-based cohort study to compare the breast cancer-related survival of patients with chronic pain who received long-term tramadol analgesic treatment with that of those who did not receive such treatment. Patients and Methods: We included patients with chronic pain and categorized them into two groups according to their analgesic use, comparing their breast cancer-related survival; patients with breast cancer and chronic pain who were prescribed ≥180 defined daily doses (DDDs) of tramadol analgesics per year >3 months before breast cancer diagnosis comprised the case group, and those who were prescribed non-tramadol analgesics before breast cancer diagnosis comprised the control group. Patients in both groups were matched at a ratio of 1:5. Results: The matching process yielded a final cohort of 624 patients (104 and 520 in the case and control groups, respectively) who were eligible for further analysis. According to both univariate and multivariate Cox regression analyses, the adjusted hazard ratio for all-cause death in the case group compared with in the control group was 3.45 (95% confidence interval = 2.36–5.04; p < 0.001). Conclusion: Long-term tramadol analgesic use prior to breast cancer diagnosis might be associated with poor overall survival in patients with chronic pain compared with such patients that did not receive long-term tramadol analgesic treatment.

show abstract

Comparison of Acute and Chronic Surgical Complications Following Robot-Assisted, Laparoscopic, and Traditional Open Radical Prostatectomy Among Men in Taiwan

Cited by 37 publications

References 44 publications

Acute, Subchronic, and Chronic Complications of Radical Prostatectomy Versus Radiotherapy With Hormone Therapy in Older Adults With High-Risk Prostate Adenocarcinoma

Acute, Subchronic, and Chronic Complications of Radical Prostatectomy Versus Radiotherapy With Hormone Therapy in Older Adults With High-Risk Prostate Adenocarcinoma

A Novel Predictive Scoring System for 90-Day Mortality among Patients with Hepatocellular Cell Carcinoma Receiving Major Hepatectomy

Survival Impact of Long-Term Tramadol Use on Breast Cancer for Patients with Chronic Pain: A Propensity Score-Matched Population-Based Cohort Study

Contact Info

Product

Resources

About